Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Sep. 8, 1999

Novel B-cell-selective immunomodulators useful in transplantation, autoimmune diseases

Sep. 6, 1999

Orally active prodigiosine compounds claimed for immunosuppression, Rx of T-cell leukemia-lymphoma

Sep. 3, 1999

PowderJect begins clinical study of DNA malaria vaccine

Sep. 3, 1999

Stanford team develops effective method for topical genetic immunization

Sep. 2, 1999

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Sep. 2, 1999

SciClone licenses new class of immunomodulators from University of California

Aug. 31, 1999

General Hospital Corp. discloses DNA vaccine for preventing, treating hepatitis C

Aug. 27, 1999

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aug. 27, 1999

Retrospective study supports safety of xenotransplantation

Aug. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...